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ABSTRACT

ARTICLE HISTORY

Background: Key elements of treatment fidelity include treatment
integrity (adherence to the treatment protocol) and treatment
differentiation (the difference in treatment ingredients in the con
trol and intervention groups). The Very Early Rehabilitation in
SpEech (VERSE) trial established treatment fidelity at the macro
level for key components of therapy.
Aims: To complete a detailed analysis of treatment integrity and
differentiation at the utterance level of a therapeutic interaction.
Methods: This was an observational study of therapy videos col
lected as part of the VERSE trial. Participants were people with
aphasia in the very early phase of recovery post stroke (n = 44)
and speech-language pathologists (n = 25). Therapist video
recorded sessions in the intensive arms of the trial (VERSEprescribed therapy and Usual Care Plus) and 53 therapy videos
(12%) were randomly selected for analysis. Therapy sessions were
transcribed, and key measures reflective of therapeutic inputs and
client acts were coded to determine treatment integrity and differ
entiation. A descriptive analysis and a Welch’s t-test for unequal
variances were used to analyse the sessional data.
Results: Therapists in the VERSE (prescribed intervention) arm of
the study, were highly adherent to the treatment protocol at the
utterance level (M = 97%). Treatment differentiation between the
intensive conditions in this sample was not achieved for cueing and
error handling suggesting the treatment delivered between groups
was similar.
Conclusions: Within this sample, treatment integrity to the pre
scribed condition was maintained. Despite significant differences
on a broad level, there was not significant differentiation in the
therapy provided in the two arms of the trial at the utterance level.
This result supports the null finding in effectiveness between the
two intensive arms of the treatment as potential key measures were
not different in dosage.
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Introduction
Treatment fidelity concept
Assessing and monitoring treatment fidelity is an important component of intervention
studies; however, a single, widely agreed upon definition has not been developed (O’Shea
et al., 2016). Most definitions, at a fundamental level, describe treatment fidelity as the
degree to which the administration of a treatment corresponds to the specified protocol for
the implementation of that treatment (Kaderavek & Justice, 2010). However, the definition of
treatment fidelity has widened over the last twenty years to incorporate the concepts of
treatment integrity, treatment differentiation, and treatment receipt (Borrelli et al., 2005).
Treatment integrity or adherence refers to the extent to which the treatment is given as
intended, while treatment differentiation determines if the therapy provided in the inter
vention and control groups is sufficiently different in relation to the key or “active” ingre
dients of the therapy provided (Moncher & Prinz, 1991). Treatment receipt is the processes
implemented to monitor and improve the participant’s ability to comprehend and perform
the behaviours targeted in the treatment (Bellg et al., 2004). This broader definition of
treatment fidelity reflects the increased complexity of research and the demand for an
evolving evidence base to guide clinical practice. To address this, there is a need to reliably
report on elements of intervention that are regularly omitted in treatment studies (Walton
et al., 2017). Strengthening processes for the planning, implementation, monitoring, and
reporting on treatment fidelity in clinical trials help to ensure that interventions are delivered
as per the study protocol, and the integrity of the treatment is preserved.
Addressing treatment fidelity can help to explain study findings, minimise errors in
interpreting study outcomes, and inform future modifications to the intervention
(Hoffmann et al., 2014). Monitoring and evaluating treatment fidelity within studies assists
in the interpretation of study outcomes and may increase confidence in the relationship
between intervention components and the outcomes of a trial (Rixon et al., 2016). While
treatment fidelity is broached with caution by some, due to the real-world applicability of
strict treatment protocol procedures (Karas & Plankis, 2016), implementation of thorough
treatment fidelity procedures has the aim of building a robust body of evidence for interven
tions. If the scientific basis for clinical practice is built on studies that have not effectively
investigated treatment fidelity, then systematic reviews, meta-analyses, and clinical practice
guidelines may be skewed (Wheeler et al., 2006). Additionally, studies with high fidelity
monitoring and reporting have increased external and internal validity and are more likely
to be replicable (Borrelli, 2011). High levels of fidelity reporting also allow comparisons to be
made between treatments (Hildebrand et al., 2012; Moncher & Prinz, 1991; Resnick et al., 2005;
Schlosser, 2002). While the importance of planning for and assessing treatment fidelity has
been highlighted, treatment fidelity processes are not always incorporated within interven
tion studies (Bellg et al., 2004). For example, Borrelli et al. (2005) evaluated 342 behaviour
change articles between 1990 and 2000 and found that overall, 54% of the studies did not
report intervention fidelity.
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Treatment fidelity in complex interventions
Complex interventions are “health service interventions that are not drugs or surgical
procedures but have many potential active ingredients” (Oakley et al., 2006, p. 413).
Behavioural interventions, such as those used in speech-language pathology (SLP), are
complex, and treatments implemented have been described as “black boxes” referring
to the fact that they may contain many potential active ingredients that shape patient
outcomes (DeJong et al., 2005; Walker et al., 2017). Additionally, due to the inherent
complexity of behavioural interventions, there may be more variation when different
sites and providers are involved in intervention studies (O’Shea et al., 2016) resulting
in potential issues with training of providers and delivery of treatment such as
contamination between conditions or therapist drift. Therapist drift refers to
a decrease in desired therapy skills or adherence to protocol over time. Treatment
fidelity is especially relevant to behavioural change interventions due to this complex
ity (O’Shea et al., 2016). Investigating therapy fidelity measures encourages researchers
to deconstruct and make explicit what is inside the “black box” of rehabilitation
intervention (Hand et al., 2018). Currently, the incorporation of treatment fidelity
processes is more established in the field of psychotherapy research compared to
medical rehabilitation research (Hildebrand et al., 2012). Treatment fidelity has been
made of such value in the psychotherapy literature that only research that includes
substantial attention to this is considered as reliable evidence for the efficacy of
a treatment. In 2008, it was recommended that psychotherapy sessions should be
videotaped and a random selection of 20% should be rated for treatment adherence
and therapy competence (Öst, 2008). Although not as established as the psychother
apy literature, increasing attention is being given to treatment fidelity in rehabilitation
interventions in stroke. Similar to psychotherapy, stroke interventions are often beha
vioural in nature, delivered via a therapist and are likely to have a range of potentially
active ingredients.
Treatment fidelity processes should be incorporated when designing a study, when
implementing the study and also when reporting the findings (Borrelli, 2011; Brogan et al.,
2019). The importance of assessing treatment fidelity has been emphasized in recent
guidelines and recommendations for evaluating complex interventions (Rixon et al.,
2016); however, guidelines are needed to define treatment fidelity concepts and to
provide standardisation regarding key aspects of treatment fidelity (Gearing et al.,
2011). The Treatment Fidelity Workgroup of the National Institutes of Health Behaviour
Change Consortium (Bellg et al., 2004) reviewed treatment fidelity practices used within
the identified literature and developed recommendations to embed treatment fidelity
practices within intervention studies. Recommendations for addressing treatment fidelity
in behaviour change studies were outlined across five main areas: study design, training
providers, delivery of treatment, receipt of treatment, and enactment of treatment skills
(Bellg et al., 2004; Borrelli, 2011). Additionally, Gearing et al. (2011) provided a treatment
fidelity guide, identifying four core components from the treatment fidelity literature with
less of an emphasis on treatment enactment, the fifth category in the Bellg et al. (2004)
framework. Gearing et al.’s (2011) guide provides a chronological outline incorporating
study design, training, monitoring intervention delivery, and monitoring intervention
receipt. The guide encourages researchers to address some broader areas of study design,
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such as the overall framework. The elements included in both the Bellg et al. (2004)
framework and Gearing et al.’s (2011) guide are very similar, with Bellg et al. (2004) being
the most widely applied in research (O’Shea et al., 2016).
Documenting fidelity involves investigating therapy effectiveness, including key ingre
dients and the dosage delivered of these (Kaderavek & Justice, 2010). Specification of
therapy ingredients is central to all areas of Bellg et al.’s (2004) framework, and dosage is
important for determining whether the therapist adhered to the protocol and whether
the intervention groups received different amounts or types of intervention. Warren et al.
(2007) proposed a comprehensive model for defining dosage and calculating cumulative
intervention intensity. The model included the term “dose form” which is defined as the
task or activity within which the teaching episodes are delivered and it may contain the
important active ingredients of the intervention. Potential active ingredients may involve
therapeutic inputs (therapist behaviours) and client acts (client behaviours) (Baker, 2012).
When designing a treatment, it is important that researchers give significant considera
tion to the theoretical underpinnings of the treatment so that the potential active
ingredients and the required dosage are identified and then adequately monitored and
evaluated (Borrelli, 2011). As such, the planning of treatments may be as complex and
detailed as the treatment itself. If researchers fail to recognise potential factors that may
facilitate change in the participants at the design stage, the appropriate data may not be
collected, evaluated, and reported (Walker et al., 2017). Specification of ingredients in the
study design allows therapists to be trained in delivering those ingredients and decisions
on the monitoring of implementation of the ingredients in therapy can be made. How to
monitor treatment delivery presents a challenge as there are few validated tools to use for
the investigation of treatment fidelity in behavioural interventions (Borrelli et al., 2005).
Treatment integrity has been incorporated as a feature of behavioural intervention
studies (Damschroder et al., 2016; Hildebrand et al., 2012; Seng & Lovejoy, 2013; Thomas
et al., 2016) with stricter protocol adherence linked to improved study outcomes
(O’Donell, 2008; Perepletchikova & Kazdin, 2005). Treatment integrity is commonly inves
tigated by measuring the therapist’s adherence to the treatment protocol through the use
of structured observations. These observations are carried out in person or via recording
and typically involve the completion of checklists (Borrelli, 2011). As a gold standard, the
checklist should be developed using a priori coding categories, which reflect the potential
factors that are identified during the development of the study design (Kaderavek &
Justice, 2010). The checklist may also be used for the collection and analysis of data for
treatment differentiation (Hildebrand et al., 2012). One criticism is that direct observation
may be more prone to bias because the treatment variable is predefined and an observer
might report what the therapist is supposed to do rather than what actually happened
(Schlosser, 2002).
Treatment fidelity information should be included in detailed treatment descriptions
and in the reporting of trial results (Moher, 2018) although this is infrequently done
(Conlon et al., 2020). Current papers may limit their investigation and reporting of
treatment fidelity to study design or protocol adherence only (O’Shea et al., 2016; Spell
et al., 2020) and not addressing the five areas of treatment fidelity (Bellg et al., 2004).
Several guidelines now exist to help authors include important intervention details
including information on treatment fidelity (Moher, 2018). For example, checklists such
as the Template for Intervention Description and Replication (TIDieR) (Hoffmann et al.,
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2014) were established to encourage more complete reporting of treatments and to
address the “remarkably poor” (p. 1) intervention description quality. While the TIDieR
checklist includes general items related to the therapy such as task selection, therapy
location, and dosage, it also includes treatment fidelity-specific items related to planned
(item 11) and actual (item 12) treatment fidelity (Hoffmann et al., 2014). These items go
beyond simple receipt of the intervention and refer to how well the intervention was
received or delivered (Hoffmann et al., 2014). With a recent emphasis on treatment
fidelity, publications addressing this area specifically within clinical trials have been
published (Behn et al., 2018; Carragher et al., 2019; Conlon et al., 2020; McLennon et al.,
2016; Resnick et al., 2011; Spell et al., 2020) providing exemplars for the reporting of
treatment fidelity analyses. This has included the specific quantitative reporting of pro
tocol adherence.

Treatment fidelity in aphasia
The adequacy of SLP randomised controlled trials (RCT) intervention descriptions, across
all SLP practice areas, not just within aphasia trials, was assessed against the TIDieR
checklist (Hoffmann et al., 2014) with 46% of studies included reporting on treatment
fidelity (Ludemann et al., 2017). Hinckley and Douglas (2013) investigated treatment
fidelity reporting within the aphasia literature and found 21/149 (14%) of studies reported
treatment fidelity between 2002 and 2011. More recently Brogan et al. (2019) reported 9/
42 (21%) aphasia RCTs published between 2012 and 2017 explicitly reported on treatment
fidelity processes. The least addressed aspect of treatment fidelity was ensuring partici
pants used the skills gained in treatment in appropriate life settings, with only two (2%)
articles including this. Poor monitoring of treatment fidelity was also reported specifically
in verb treatments (Hickin et al., 2020).
Increasingly published research protocols are using the current gold standard techni
que of video recording therapy sessions and assessing these according to a priori criteria.
These studies include the Aphasia Action Success Knowledge (ASK) trial (Worrall et al.,
2016), Predicting and Promoting Sub-acute Aphasia Recovery (PAPAR) (Copland, 2017),
SUpporting well-being through PEeR-Befriending (SUPERB) trial (Behn et al., 2018) and the
COMPARE trial (M. Rose et al., 2019). Other studies such as BIG CACTUS (Palmer et al.,
2015) have advantages with computerised therapy in obtaining fidelity data via logs
without relying on therapist reports or monitoring therapist participant interactions. An
additional level of therapy fidelity is the monitoring of recorded sessions and providing
feedback to the therapist to change aspects of their therapy delivery and increase
protocol adherence, while treatment is still being delivered. ASK (Carragher et al., 2019),
COMPARE (M. L. Rose et al., 2019) and VERSE (Godecke et al., 2020b) have incorporated
this element.

Very Early Rehabilitation in SpEech (VERSE) trial
This study involved the analysis of a subset of data from the VERSE trial. The findings of
the VERSE trial indicated that communication outcomes were equivalent for usual care
therapy and early intensive therapy at 12 and 26 weeks post stroke (Godecke et al.,
2020b). Usual care was documented to be therapy provided an average of two to three
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times per week for approximately 40 min (9.5 hours in total in the first 50 days after stroke)
and this resulted in improved communicative ability after stroke as measured by the
outcome on the Western Aphasia Battery Revised – Aphasia Quotient (WABRAQ) (Kertesz, 2006). Intensive intervention (22 hours in total in the first 42 days after
stroke) provided within the Usual Care-Plus and the prescribed VERSE intervention arms
of the trial did not cause harm but did not provide a statistically significant benefit to
participants over and above the usual care regimen (Godecke et al., 2020b).
The interventions in the trial were as follows:
(i) Usual Care: Participants randomised to this group received care that is typical for
aphasia management in the Australian and New Zealand healthcare settings and
was at the discretion of the treating SP. It also included management of other
speech pathology impairments such as dysphagia, dysarthria, and/or apraxia of
speech. Only direct aphasia therapy time was included in the analysis for the
primary VERSE result. Usual care therapy was recorded over a period of 20 working
days.
(ii) Usual Care-Plus: Participants received treatment that is typical of direct aphasia
therapy, at the discretion of the treating SP as per the Usual Care group, but with
a defined intensity therapy regimen of daily sessions for 45–60 minutes duration
over 20 sessions. Direct aphasia therapy included 1:1 impairment-based therapy,
impairment-based computer training, social training, group impairment-based
therapy, group social training, and Augmentative and Alternative
Communication (AAC) training.
(iii) VERSE intervention: The intensity of this arm of therapy matched that of the Usual
Care-Plus arm but the intervention was impairment-based, prescribed, and stan
dardised according to a specific VERSE intervention protocol. As per treatment
fidelity recommendations, when planning the prescribed intervention, the theore
tical underpinnings of the treatment were highlighted, allowing these to be
monitored and evaluated. This intervention was founded on principles to promote
neurorecovery: i) massed practice, ii) error-free learning, iii) task complexity, iv)
salience, and v) maximising communicative success.

The current study
Treatment fidelity processes were developed and implemented within the VERSE trial.
Treatment integrity and differentiation were established in the main study, at a broad
level, between treatment conditions. However, with a trial of this size, including 8915
completed therapy sessions, fine-grained analysis of all therapy sessions was not feasible.
The researchers placed importance on investigating a proportion of the sample with
greater detail. In the present treatment fidelity study, we investigated the dose form, as
per Warren et al. (2007), given in the two arms of the trial to establish treatment integrity
and differentiation. In the VERSE trial, the intensity was prescribed for the two intervention
arms at twenty sessions; however, the dose form given and received within a session was
not prescribed. This therefore provides an opportunity to investigate treatment integrity
and differentiation. According to Baker (2012) dose form involves both the therapeutic
inputs and client acts of a task. Therapeutic inputs refer to behaviours by the therapist
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within the task that are thought to be therapeutic in nature. Similarly, client acts are
behaviours that may contribute to the therapeutic effect. Integrity and differentiation
results have been framed according to these elements within the current study. As the
interventions provided within the VERSE RCT were behavioural and interactional in
nature, treatment integrity and differentiation were investigated at the utterance level
in this study, with the following aims:
(i) To determine treatment integrity (protocol adherence) for the task (dose form) and
therapeutic inputs (cueing and error handling) to the VERSE intervention protocol.
(ii) To determine the level of treatment differentiation (dose form given within ses
sions) for the task, therapeutic inputs (cueing) and client acts (verbal output, errors),
between the intensive conditions (Usual Care-Plus and VERSE) at the utterance
level.

Method
Participants
This study used therapy videos collected as part of the VERSE RCT. Participants were
recruited to the VERSE trial if they had aphasia secondary to an acute intracerebral
haemorrhage or ischaemic stroke; were 18 years of age or over; had corrected hearing
and vision; were medically stable at or before 14 days post stroke; and could participate in
aphasia therapy in English without the need for an interpreter. Exclusion criteria included
pre-existing aphasia prior to admission into the hospital; a history of progressive neuro
logical disease, neurosurgery, major depression, subdural or subarachnoid haemorrhage;
and an inability to maintain alertness for 30 consecutive minutes at 14 days post stroke.
VERSE recruited 246 participants, 81 in Usual Care, 82 in Usual Care-Plus, and 83 in VERSE,
across Australia and New Zealand. Participants were assessed at a baseline of 12 and
26 weeks post stroke on a range of impairment, psychosocial, and economic measures.
The primary outcome measure for VERSE was the WABR-AQ (Kertesz, 2006) at 12 weeks
post stroke.
The participants for the current study represent a sample subset from the broader
VERSE RCT. As part of the treatment fidelity processes embedded within the VERSE RCT,
VERSE and Usual Care-Plus therapists were required to video record one therapy session
per week, resulting in four or five recordings per participant (please see below for more
details on the VERSE RCT treatment fidelity processes). For practical reasons, it was
suggested to therapists to video record session numbers five, 10, 15, and 20, however,
therapy videos for any session were accepted.
An independent research assistant used a computer-generated block randomisation to
select therapy videos for this study. This process was stratified for aphasia severity (mild,
moderate, and severe aphasia as determined by the WABR-AQ at baseline). For the videos
to be included within the study, participants were required to have outcome scores at
12 weeks (primary outcome) and 26 weeks on the WABR-AQ and have completed the full
treatment protocol. Additionally, videos needed to be at least 40 min in length, not
contain the present author as the therapist and be playable on Windows Media Player.
The sample comprised 53 videos, which was 12% of the 434 therapy videos received
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Table 1. Participant demographic and stroke characteristics.
Demographic
Age, Mean (SD)
Female
Oxford Stroke Classification c
Haemorrhagic
PACs
PoCs
TACs
Baseline WABR-AQ Severity
Mild
Moderate
Severe
Modified Rankin Scale Score (mRS)
Low disability (mRS 0–2)
High disability (mRS 3–5)
National Institutes of Health Scale Score, Mean
(SD)

Whole
group
(n = 44)a
72.0 (14.8)

Usual CarePlus
(n = 19)
68.0 (14.7)

VERSE High Intensity
cohort
(n = 164)b
75 (18)

7 (37%)

80 (49%)

19 (43%)

VERSE
(n = 25)
75.0
(14.2)
12 (48%)

3 (7%)
34 (77%)
1 (2%)
6 (14%)

2 (8%)
18 (72%)
0 (0%)
5 (20%)

1 (5%)
16 (84%)
1 (5%)
1 (5%)

13 (8%)
110 (67%)
6 (4%)
35 (21%)

15 (34%)
13 (30%)
16 (36%)

8 (32%)
7 (28%)
10 (40%)

7 (37%)
6 (32%)
6 (32%)

47 (29%)
49 (30%)
68 (41%)

6 (14%)
38 (86%)
9.1 (7.1)

5 (20%)
20 (80%)
9.4 (7.5)

1 (5%)
18 (95%)
8.7 (6.5)

16 (10%)
148 (90%)
9 (6)

Note. a Within this substudy, 53 videos were selected through randomisation with 8 participants having more than one
video in the sample. Therefore, 44 different participants are included in this demographics table. b This column
represents the VERSE high intensity cohort as a whole from the primary study for comparison purposes. c PACs = Partial
Anterior Circulation syndrome; PoCs = Posterior Circulation syndrome; TACs = Total Anterior Circulation syndrome.

through the trial. See Table 1 for participant demographics included in this study. Of the
53 randomly selected videos, seven participants had two videos in the sample (total 14
videos), one participant had three videos in the sample (total of 3 videos), and the
remaining 36 participants had one video each (total 36 videos). This resulted in the
inclusion of 44 different participants. Twenty-seven SLPs are also included in the videos.
SLPs were hired specifically for the trial and were required to be eligible for membership
to Speech Pathology Australia. All treating SLPs underwent training (3 hours) and received
procedural and training manuals relevant to the arm of therapy they were providing.
Clinical support was provided by trial clinical staff as required throughout the trial. VERSE
therapists were then given additional training (2 hours) to administer the prescribed
therapy (Godecke et al., 2020a).

Treatment fidelity within VERSE
All therapists within the trial completed standardised therapist training, including the
provision of manual and logged session data. Additionally, therapists in the intensive
arms of the trial (Usual Care-Plus and VERSE) were required to video record a set number
of sessions across the intervention period. The Therapy Fidelity Monitor (TFM) checked
that therapy for participants in the intensive arms of the study was commenced on or
before day 15 post stroke and that it did not continue beyond 50 days post stroke. The
duration and frequency of each session within the intensive arms of the trial were also
monitored to ensure it was 45–60 minutes of direct aphasia therapy, for a maximum of
five sessions per week for 20 sessions and completed within 4 weeks. For the prescribed
VERSE intervention arm, key therapy ingredients were identified within the study design.
This guided therapist training and the monitoring of therapy delivery. VERSE intervention
therapists received a specific therapy manual and received one on one support in order to
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implement the therapy as prescribed. The TFM monitored that prescribed targets as per
the protocol were met, including delivering conversation-based therapy at the target goal
level. They also monitored major VERSE protocol elements broadly, such as the timing and
type of cueing used by the therapist and scaffolding of correct productions. This resulted
in an overall rating of the session as adherent or non-adherent to VERSE protocol. The TFM
and Therapy Fidelity Co-ordinator was responsible for feeding back to the therapists
about any deviations from the VERSE protocol or any general questions that arose about
the treatment procedures.

Procedure
Transcription
In this study, each video was transcribed verbatim and utterances segmented following
the guidelines provided within the Systematic Analysis of Language Transcripts (SALT)
(Miller, 2008) software and as per SALT guidelines (available at http://saltsoftware.com/
resources/tranaids).
Coding
During transcription, codes developed specifically for this research were applied at the
word and utterance level of the transcript for both therapeutic inputs and client acts.
Variables of interest were selected as possible key points of difference between treat
ments based on the theoretical underpinnings of the VERSE therapy protocol. For exam
ple, the quantity and accuracy of the participant’s production was a key consideration as
the VERSE protocol incorporated the principle of maximising communicative success
through the use of salient communication-based tasks and error minimisation strategies
(error-free production). Rationales for the coding systems are explained in the relevant
sections below.
Treatment integrity – protocol adherence.
Task (dose form). Integrity or adherence to the VERSE prescribed treatment required
therapists to implement conversation-based tasks aimed at eliciting an accurate phrase
structure at the appropriate level for the participant. This appropriate level is called a “goal
level”. The rationale for verbal conversation tasks in the VERSE protocol was i) that
improvement in therapy is experience dependent; ii) a lack of experience of practicing
a task may result in learned non-use; and iii) conversation is salient to the person with
aphasia, a key neuroplasticity principle (Pulvermuller & Berthier, 2008).
A summary of the goal levels of the prescribed treatment and subsequent coding is
presented in Table 2. For example, if goal two was chosen as the starting point for the
participant based on baseline data, the therapist was trained to facilitate the production
of verbal output at a minimum of single word level. If the participant independently
achieved 80% success during the session, they progressed to the next goal. Utterances
from the participant were coded as either at, above, or below the targeted goal level. The
target goal level of each session was coded, to account for incremental improvement
throughout the treatment period. These codes were then counted to allow a calculation
of the percentage of utterances that were at or above the target goal level. The mean
length of utterance (MLU) during the therapy session, as per the SALT analysis, was also
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Table 2. Summary of coding for task adherence.
Goal
level
1a
1b
1c
2

Definition
Receptive: Identification of
verb pictures from spoken
words
Receptive: Identification of
noun pictures from spoken
words
Receptive: Identification of
adjectives pictures from
spoken words
Verbal production of single
words

3

Verbal production of two
element phrases or clauses

4

Verbal production of three
element phrases or clauses

5

Verbal production of complex
clauses and/ or phrases

6

Verbal production of complex
phrases (verb and noun) and
clauses
Verbal conversation about
familiar topics
Verbal conversation about
unfamiliar topics

7
8

Utterance level coding
Any verbal output is appropriate. Cannot mark as
being below goal level. Can mark as above goal level
for any verbal output that is not an error.

Minimum MLU
Expected in
Session
0
0
0

If not responding verbally then mark as below the
1
appropriate goal level. Can mark as above goal level if
above this level.
If responding at single-word level including yes/no
2
responses then mark as below the appropriate goal
level. Can mark as above goal level if above this level.
If responding below three element clause then mark
3
as below the appropriate goal level. Can mark as
above goal level if above this level.
If responding with three element clauses or less then 4
mark as below the appropriate goal level. Can mark as
above goal level if above this level.
If responding below a complex phrase mark as below 5
the appropriate goal level. Can mark as above goal
level if above this level.
Cannot mark as above goal level. At conversation level >5
utterances must be above a complex phrase otherwise
they will be marked as below the appropriate goal
>5
level.

Note. MLU = Mean Length of Utterance

used to determine protocol adherence to see whether it matched the predetermined goal
level of the session. This measure is average and broader than the utterance by utterance
analysis. The MLU analysis provides an overall measure of the mean length of utterance
for the entire session, whereas the utterance analysis was a point-to-point count.
Therapist inputs. The video transcriptions for the VERSE intervention group were coded
according to therapeutic inputs that adhered to VERSE treatment elements and those that
did not. All therapist utterances that did not meet the criteria for non-adherence were
deemed adherent to the therapy protocol. After coding and counting, a percentage of
therapeutic inputs that adhered to VERSE treatment elements for each session was
established.
There was a specific focus on how the therapist responded to participant errors with
cueing. Cues were used by the therapist to promote accuracy and participation by
assisting in word retrieval and/or accurate speech production. In the VERSE protocol,
therapists were required to establish the type of cue that is most effective for the
participant. Therapists were encouraged not to repeat cues that were ineffective. An
utterance would be marked as a protocol deviation if the therapist used the same cue
type more than once for the same stimulus and it was unsuccessful.
VERSE therapy incorporated the principle of error-free practice. Therefore, therapists
were encouraged to limit the participant to no more than three errors on a stimulus. The
utterance was marked as a protocol deviation if the participant made more than three
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errors for one stimulus and a model was not given after the third error. Every subsequent
cue and utterance for the same stimulus by the therapist, which allowed the participant to
continue making errors, was marked as a protocol deviation.

Treatment differentiation.
Task (dose form). Tasks were coded with a description of the activity (e.g., picture
naming), the target language process (i.e., expressive verbal, expressive written, receptive
auditory, or receptive written) and the target phrase level (i.e., single-word level, sentence,
or conversation) to enable dose form differentiation. For conversation to be included as
a task, it needed to be the target of therapy, including therapeutic inputs such as cueing
and feedback. Filler conversation and rapport building at the beginning or end of the
session was not included.
Therapist inputs. Measures related to therapeutic inputs were coded in order to assess
whether the treatment provided in the two intervention groups was significantly differ
ent. The therapeutic inputs of interest were related to cueing. The specific cues focused
on in this study were phonemic, semantic, orthographic, visual, forced alternative, sen
tence completion, articulatory placement, and direct model cues. A cue was coded if
a relevant cue was used by the therapist. If the cue was successful in eliciting an
appropriate response from the participant, it was marked as a cue used with success.
Turkstra et al. (2016) suggested investigating ingredients, such as handling of errors and
their effect on target attainment, more generally across a therapy session rather than
looking at the impact of these ingredients separately for each activity. This approach was
used within this study and so the treatment sessions were examined as a whole to analyse
therapist tailoring of cues and whether the use of the cues resulted in successful partici
pant/client performance. Codes were then counted to provide totals and percentages for
each session. In addition, calculations were performed by the SALT software (total
therapist utterances, total therapist words, and utterances per minute) and used in the
analysis.
Client acts. Measures related to client acts were coded to assess whether the partici
pants’ response to the treatment provided in the two intervention groups was signifi
cantly different. Aphasia treatment approaches are often described as “error full” or
“errorless” referring to whether patients are encouraged to attempt target attainment
irrespective of the error quantity or whether errors are minimized to avoid strengthen
ing of associated negative neural networks. Reducing errors in therapy relates to
Hebbian theory surrounding coactivation of neurons and that a mistake occurring
while producing a word may wire together these two behaviours (Hebb, 1949; Varley,
2011). It aims to avoid therapy being the practice of errors (Varley, 2011). Errorless
learning may reflect implicit learning techniques that may be suited to the motor
learning required in speech production (Page, Wilson, Norris 2006). As such, the
codes of focus reflected the quantity and accuracy of utterances. Each utterance was
marked as error free if it contained no errors. An error made by the participant was
marked at the word level. It was further coded for error types including filled and
unfilled pauses, phonology, perseveration, circumlocution, semantic, grammatical,
repetition fluency, receptive, and unintelligible errors. Errors that were self-corrected
prior to therapist intervention were coded as self-corrections. The codes were then
counted to provide totals and percentages for each session. In addition, calculations
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were performed by the SALT software and used in the differentiation analysis. These
were mean length of utterance (MLU) in both words and morphemes, total verbal
utterances, total words, words per minute (WPM), utterances per minute (UPM) and
mean turn length in words.
Additionally, calculations were performed manually according to the formulas in Table
3 and used in the analysis.

Statistical analysis
Descriptive statistical analyses for treatment integrity and differentiation measures
were completed. As the session length of the videos was not equal, the time of the
session was used to standardise the data [measure/session time (mins)] for the
following measures: total error-free utterances, total errors, spontaneous verbal out
put, total self-corrections, total verbal utterances, total words, utterance-level errors,
word-level errors, total cues used with success, total therapist utterances, and total
therapist words. A Welch’s t-test for unequal variances was performed using the
above measures to determine whether Usual Care-Plus and VERSE conditions were
significantly different. This test was used as it is robust to unequal sample sizes.
A Bonferroni correction was applied for multiple comparisons and significance was
set at p< 0.001.

Reliability
Six videos (one from each aphasia severity in Usual Care-Plus and VERSE groups) were recoded for inter- and intra-rater reliability. This comprised 11% of the total sample in this
study. Reliability was established using the intra-class correlation coefficient (ICC) in SPSS
(IBM Corp, 2015) with a consistency 2-way mixed-effects model. The ICC was established on
the four key measures of interest in the study – error-free utterances, total errors made, (iii)
total self-corrections, and (iii) the total number of cues used with success by the therapist.
Koo and Li (2016) guidelines for reporting the ICC have been adhered to in the tables below.

Table 3. Client act calculations for differentiating treatments.
Calculation
Spontaneous verbal
utterances
Utterance Level Errors
Word Level Errors
% errors self-corrected
Average no. of errors per
utterance
Average no. of utterances
per error
% total words with errors
Verbal utterances

Formula
The number of verbal utterances that were generated spontaneously, e.g., not
a repetition of a model or a gesture (verbal utterances) – (repetitions + gestures)
Total of the number of errors that occur at the utterance level based on codes in the
transcript.
Total of the number of errors that occurred at the word level based on codes in the
transcript.
Self-corrections/Total errors x 100
Verbal errors/Verbal utterances
Verbal utterances/Verbal errors
Errors/Total words x 100
Total utterances – Gestures
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Inter-rater reliability
As per Supplement 1, three of the measures had ICCs in excess of 0.90, and, therefore, interrater reliability can be said to be excellent. The self-corrections measure was lower; how
ever, ICCs in the range of 0.75–0.90 remain in the good reliability range (Koo & Li, 2016).
Intra-rater reliability
Intra-reliability is rated as excellent, given the ICCs are all in excess of 0.90 as per
Supplement 2.

Results
Treatment integrity
Protocol adherence-task (dose form)
The majority of participant utterances within tasks were at the target goal level. The goal
level refers to the target verbal output level during the session and ranges from a target
MLU of 0 to >5. An average of 67% of utterances was at the target goal level within
a session. On average, 8% of utterances by the participant in a session were above the
target goal level of the session. Table 4 provides descriptive statistics for the therapists’
adherence to the target goal level for the VERSE condition measured at the utterance
level.
A higher level of dosage adherence was seen using the MLU analysis compared to the
utterance by utterance dosage adherence measures above. The MLU analysis provides an
overall measure of the mean length of utterance for the entire session, whereas the
dosage adherence measures above were point-to-point count. Of the 28 VERSE sessions
analysed, 24 (86%) had an MLU at or above the target goal level for the session. This
represents a high level of protocol adherence.
Protocol adherence – therapeutic inputs
Therapists produced, on average, 671 utterances (SD = 278.1) per session in the VERSE
condition. There were on average 15 protocol deviant utterances per session (inclusive of
the same cue and error deviations) with 97.6% of utterances by the therapist being
adherent to the VERSE intervention protocol. Where deviations were observed, allowing
the participant to make more than three errors was observed most frequently, occurring
on average ten times per session (1.5%). Table 5 summaries the protocol adherence data
with descriptive statistics.

Treatment differentiation
Task (dose form)
Descriptive statistics for the tasks completed in this study are presented in Table 6. The
prescribed protocol was designed to focus on verbal language output and encourage
conversation. The VERSE therapy group had a greater percentage of verbal and conversa
tion-level tasks.
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Table 4. Measures of central tendency for protocol adherence to task.
Measure
Error free and at appropriate goal level
Mean (SD)
Median
Interquartile range (IQR)
% total utterances
Error free not at appropriate goal levela
Mean (SD)
Median
IQR
% total utterances
Contains an error and at the appropriate goal level
Mean (SD)
Median
IQR
% total utterances
Contains an error and not at appropriate goal level a
Mean (SD)
Median
IQR
% total utterances
Above goal level
Mean (SD)
Median
IQR
% total utterances
% utterances above goal level
Mean (SD)
Median
IQR
Not at target goal level
Mean (SD)
Median
IQR
% utterances at correct goal level
Mean (SD)
Median
IQR

VERSE (n = 28 videos)
197.2 (124.6)
172.5
161
38.6%
128.4 (87.6)
122.0
114.0
25.1%
185.7 (123.9)
149.0
129
36.4%
64.0 (56.3)
48.0
55.0
12.5%
36.2 (31.7)
31.0
63.0
7.0%
8.2 (8.5)
6.1
12.1
192.4 (124.3)
159.0
175
67.2 (24.4)
66.3
38.2

Note. a Not at appropriate goal level includes utterances that were below the target goal
level only.

Table 5. Means and standard deviations for session protocol
adherence – therapeutic inputs.
Measure
Total deviant utterances Mean (SD)
Protocol deviant utterances (same cue)
Protocol deviant utterances – x 3 errors
Protocol adherent behaviours
% Utterances that adhere to protocol

VERSE (n = 28 videos)
14.9 (17.3)
4.3 (7.5)
10.0 (12.5)
656.3 (273.6)
97.6 (3.2)

Therapist inputs
Descriptive statistics for therapeutic inputs are presented in Table 7. To maintain context,
the means and standard deviations are presented in raw format prior to time adjustment
[measure/session time (mins)]. After statistical analysis, the groups were not found to be
significantly different with p > 0.001.
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Table 6. Tasks for overall treatment differentiation.
Measure
Total number of tasks
Total number of verbal tasks (%)
Total verbal tasks at single word level (%)
Total verbal tasks at conversation level (%)

Whole group
(n = 53)
152
114 (75%)
53 (46%)
16 (14%)

VERSE
(n = 28)
56
48 (86%)
13 (27%)
12 (25%)

Usual Care-Plus
(n = 25)
96
66 (69%)
40 (61%)
4 (6%)

Table 7. Descriptive and t-test statistic for treatment differentiation – therapeutic inputs.
Measure
Therapist total utterances Mean (SD)
Cues used with success by therapist
Total cues used by therapist
% Cues that were successful
Therapist total words
Therapist utterances per minute

VERSE
(n = 28 videos)
671.1 (278.1)
29.6 (27.4)
77.3 (72.3)
41.5 (20.0)
2687 (948.5)
12.5 (4.9)

Usual Care-Plus
(n = 25 videos)
679.6 (226.0)
38.5 (48.5)
86.6 (74.8)
38.2 (26.9)
2848.6 (857.9)
14.5 (7.6)

p value
.577
.424
.631
.625
.518
.283

Table 8. Descriptive and t-test statistic for treatment differentiation – client acts.
Measure
Total Verbal Utterances Mean (SD)*
Error free utterances*
Errors*
Spontaneous verbal*
Self-Corrections*
% errors self-corrected
Total words*
MLU (words) a
MLU (morphemes) a
Average errors per utterance (errors/utt.)
Average utterances per error (utt/errors)
Utterance Level Errors
Word Level Errors*
% total words with errors
Utterances per minute
Words per minute

VERSE
(n = 28 videos)
474.2 (213.7)
311.8 (135.5)
242.9 (134.6)
250.0 (161.0)
49.2 (64.0)
17.6 (18.1)
1847.4 (1460.7)
3.5 (2.1)
3.9 (2.3)
0.5 (0.3)
2.4 (1.3)
24.3 (27.2)
232.4 (162.0)
33.5 (52.1)
9.7 (3.1)
35.7 (27.7)

Usual Care-Plus
(n = 25 videos)
483.4 (225.1)
302.5 (139.6)
211.9 (135.7)
257.3 (144.5)
22.0 (22.0)
12.6 (14.4)
1511.6 (1128.2)
2.9 (1.4)
3.2 (1.5)
0.4 (0.2)
2.8 (1.3)
23.4 (34.0)
227.4 (162.3)
22.5 (25.5)
9.8 (3.6)
29.5 (19.8)

p value
.651
.979
.521
.661
.040
.276
.402
.230
.212
.115
.349
.854
.997
.326
.892
.355

Note. a Mean Length of Utterance, * Variables that were adjusted for time as the session length of the videos was not
equal (measure/session time (mins).

Client acts
Descriptive statistics for client acts are presented in Table 8. To maintain context, the
means and standard deviations are presented in raw format prior to time adjustment
(measure/session time (mins)). After statistical analysis, the groups, Usual Care-Plus, and
VERSE were not found to be significantly different with p > 0.001.

Discussion
This study sought to establish treatment integrity and treatment differentiation for the VERSE
trial in a detailed transcript analysis of the therapy sessions. VERSE was the largest RCT in early
aphasia recovery completed to date. The analysis of the wealth of treatment fidelity data
collected in the trial is imperative to further analyse and interpret the trial outcomes.
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Treatment integrity
Results in this sub-study suggest therapists, providing therapy in the intensive VERSE
arm of the trial, were adherent to the prescribed treatment protocol. This was estab
lished by measuring the therapists’ adherence to the target task level. On average, the
target level of verbal output was achieved in 67% of participant utterances in this
sample of sessions from the VERSE arm, as per protocol. When looking at a broader
session view, the target phrase structure achieved 86% of the time when measured by
the mean length of utterance. Protocol adherence for the therapeutic inputs was high
at 98% with minimal deviations. Therefore, the key VERSE elements of minimising
errors and encouraging verbal output were delivered by the therapist, and it is possible
to establish treatment integrity to the dose form within this sample. There is no
accepted minimum level of integrity that is required in a complex, behavioural RCT;
however, the TF literature suggests protocol adherence of 80% or greater to be
considered as a high fidelity level (Borrelli, 2011; Borrelli et al., 2005; Perepletchikova
& Kazdin, 2005). Regardless, it is important to report what was intended compared to
what was received (Brogan et al., 2019). Additionally, adherence to the intensity of the
protocol is more commonly reported than adherence to key therapeutic elements
within sessions (Bakheit et al., 2007; Resnick et al., 2011). However, this study has
shown that it is possible for aphasia studies to monitor adherence to key therapeutic
elements within therapy sessions and report quantitative values for this. Our findings
are consistent with other levels of reported protocol adherence in the aphasia litera
ture, in excess of 90% therapist adherence (Behn et al., 2018; Conlon et al., 2020).
A current therapy fidelity protocol for the Action Success Knowledge (ASK) trial has set
integrity at 100% adherence to essential therapeutic criteria in a session and 80%
overall adherence to protocol to deem therapists as meeting criteria (Carragher et al.,
2019). It is important to note that instances where sessions deviated from the target
goal level may have been a reflection of clinical intuition and responsiveness to the
participant and inadvertently caused infidelity to the treatment protocol.

Treatment differentiation
At the broader task level, the VERSE treatment arm contained more verbal output, less
single-word tasks, and more conversation-based tasks than the Usual Care-Plus treatment
arm as per protocol. However, when the therapeutic inputs and client acts were examined
at the utterance level, the treatments did not differ significantly. As expected, the tasks
completed in the prescribed VERSE therapy were different from the treatment provided in
Usual Care-Plus, however the therapist input, related to the amount of cueing provided to
support participant success as well as the amount of language produced by the therapist,
was similar for therapists in both arms of the trial. It may be that even if different therapy
tasks were used, the manner in which clinicians supported the participants within the
treatment sessions was similar. This may reflect clinicians’ perspectives around best
practice for supporting patients in treatment sessions or their understanding of facilitat
ing neural recovery through limiting errors and providing individual opportunities to
produce verbal output. A related explanation concerns the underlying theoretical
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mechanism underpinning language therapy. As hypothesized previously, the underlying
therapeutic mechanism at work in language therapy may be irrespective of task or
therapeutic inputs (Godecke et al., 2016).
In exploring treatment fidelity, it is important to consider the way in which the therapy
is delivered as well as the role of the person who receives the therapy, the person with
aphasia in this case (Bellg et al., 2004). People with aphasia are a heterogeneous popula
tion (Brady et al., 2016), with considerable variation in relation to how aphasia may
present. Even within the same aphasia classification, such as Broca’s or Wernicke’s
aphasia, the number of errors made or the types of cues that are helpful may be very
different from one person to the next. However, homogeneity can be observed within
PWA during therapy. The tasks used between therapy groups and between therapists
were different; however, the interaction frequently elicited the same behaviour from
people with aphasia. It is possible that people with aphasia were reasonably predictable
once their individual error pattern and response to cues was established. Therefore,
regardless of the assigned therapy group, the presence or absence of a protocol, the
therapist’s attempts to manipulate a session, minimise or maximise errors, PWA
responded in a particular pattern. And so, another possible explanation for the lack of
treatment differentiation at the utterance level in client acts is that regardless of the
therapy provided, the response of PWA was similar across the intervention groups. This
may relate to the reinforcement of error patterns by PWA regardless of the approach
taken by the therapist (Conroy et al., 2009).

Interpretation of main trial results
Therapy fidelity data is vital to support the interpretation of the main trial outcomes,
especially in behavioural research (Walton et al., 2017). The main VERSE trial results found
that there was not a main effect for treatment intensity (Godecke et al., 2020b). Clinicians
within in the VERSE and Usual Care-Plus arms of the trial were required to record 20% of their
treatment sessions, in line with recommendations for long-term monitoring (Borrelli, 2011).
This study provided a detailed examination of 12% of the videos received through the trial.
As this is only a small percentage of the total number of therapy sessions completed, we
cannot say with certainty whether this sample is representative of all therapy given, how
ever, we feel the analyses completed and results found provide important insight into the
therapy provided within this trial. If the results from this study are extrapolated to the
broader VERSE RCT the findings suggest that therapists were adherent to the therapy
protocol for the prescribed VERSE arm of the trial and that while the therapies, provided
in the VERSE and Usual Care-Plus arms of the trial, contained different tasks and target
language levels, how the therapists interacted with participants was not different.
Specifically, the number of cues used by therapists to support participants, the success of
these cues, the amount of verbal output from the therapist, and the PWA, were not
significantly different. We are cautious with extrapolating this result to the entire VERSE
RCT sample, however it could provide one potential explanation for why the prescribed
VERSE therapy arm and Usual Care-Plus did not perform differently in statistical analyses for
the primary outcome measures. It is likely that both conditions share the key elements of
aphasia therapy, that is therapists within the Usual Care-Plus condition provided treatment
elements at the micro level that share the key elements of the VERSE intervention. This may
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relate to the VERSE intervention being a good reflection of existing practice, therefore
promoting adherence. Additionally, therapists delivering Usual Care-Plus may already have
been employing the key neuroplasticity principles that the VERSE prescribed intervention
contained. It is unlikely that this is due to contamination between conditions as the VERSE
intervention was shown to be statistically different at the task level of intervention
prescription.

Recommendations for future trials
We would encourage researchers to undertake fine-grained analyses of treatments
provided within complex, behavioural interventions in the early (pilot) phases of
intervention studies. These fine-grained analyses may reveal important underlying
factors in the way the intervention is provided or received by participants that require
further investigation and understanding in order to interpret trial results. Examining
differentiation in the treatments provided may not be sufficient if participant behaviour
or acts have the potential to impact clinician behaviour as the therapy session pro
gresses. It will be important to consider this relationship further in complex behavioural
trials.
This study established that reviewing aphasia therapy videos from an RCT and coding
these for key measures is feasible, however data analyses were lengthy due to the indepth nature of the analyses completed. Further research is needed to develop
a greater understanding of the behaviours that should be investigated in establishing
treatment integrity and differentiation and the most efficient ways of evaluating these
components. As this study was the first undertaken of this nature, a scoping process was
used. If a pilot study is used and the researcher is confident that key intervention
ingredients have been identified resulting in a more targeted approach, the practic
ability may be increased.

Limitations
This study is the first of its kind to provide a detailed analysis of therapy sessions within an
aphasia-based RCT. However, it is acknowledged that a small number (12%) of the
available trial videos were analysed and so there is a limit to the extrapolation of results
to across the trial as a whole. It is also possible that the study was underpowered to find
differences between the groups. The primary rater for the videos was not blinded to the
treatment condition; however, unblinding was necessary for monitoring protocol adher
ence, and treatments were also easily distinguishable based on task selection. We do
acknowledge the potential for bias.

Conclusion
Aphasia RCTs are encouraged to routinely report therapy fidelity data to assist research
consumers with their interpretation of trial results. We report high treatment integrity
within the VERSE trial. Determining the active ingredients and dosage level to ensure
treatment differentiation is an ongoing goal for aphasia trials. Micro-level analysis of
therapy sessions may reveal important underlying factors for further investigation and
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only when the treatments are determined to be sufficiently different and the target
dosage is achieved, can the efficacy question be answered.
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